LLY · News · 20260917N

Market Demand - Retatrutide Black Market

ELI LILLY & Co · 2026-09-17 · Importance 31 · Surprise 42

A CBS News investigation found companies marketing and selling retatrutide online to U.S. consumers. Retatrutide is Eli Lilly’s experimental weight-loss medicine and remains in clinical trials without approval for commercial sale. The activity creates counterfeit, product-safety, and channel risks around demand for Lilly’s next-generation obesity pipeline.

Key facts

• Retatrutide, an experimental weight loss drug developed by Eli Lilly and still in clinical trials, is being illegally marketed and sold online to consumers in the U.S. source